Compound Detail
CHEMBL5176659
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5176659 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RSXNHHDVMXZIJO-UHFFFAOYSA-N |
5
Targets
6
Activities
1
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
401.5
MW (Da)
3.85
ALogP
5
HBA
0
HBD
45.7
PSA (Ų)
0.46
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 5.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NCI/ADR-RES CHEMBL613829 | IC50 | 5.75 | 5.315 | 1800.0 | 2 |
| MCF7 CHEMBL387 | IC50 | 5.06 | 5.06 | 8670.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.96 | 4.96 | 11080.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.95 | 4.95 | 11140.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.92 | 4.92 | 11910.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NCI/ADR-RES | IC50 | = | 1800.0 | nM | 5.75 | Reversal of multidrug resistant activity in human MCF7/ADR cells after 48 hrs by... | 35339100 |
| MCF7 | IC50 | = | 8670.0 | nM | 5.06 | Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay | 35339100 |
| MDA-MB-231 | IC50 | = | 11080.0 | nM | 4.96 | Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT as... | 35339100 |
| A549 | IC50 | = | 11140.0 | nM | 4.95 | Antiproliferative activity against human A549 cells after 48 hrs by MTT assay | 35339100 |
| HepG2 | IC50 | = | 11910.0 | nM | 4.92 | Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay | 35339100 |
| NCI/ADR-RES | IC50 | = | 13210.0 | nM | 4.88 | Antiproliferative activity against human MCF7/ADR cells after 48 hrs by MTT assa... | 35339100 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35339100 | 10.1016/j.ejmech.2022.114300 | MCF7 | 2 |
| 35339100 | 10.1016/j.ejmech.2022.114300 | NCI/ADR-RES | 2 |
| 35339100 | 10.1016/j.ejmech.2022.114300 | A549 | 1 |
| 35339100 | 10.1016/j.ejmech.2022.114300 | HepG2 | 1 |
| 35339100 | 10.1016/j.ejmech.2022.114300 | MDA-MB-231 | 1 |
| 35339100 | 10.1016/j.ejmech.2022.114300 | L02 | 1 |
| 35339100 | 10.1016/j.ejmech.2022.114300 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine